Photo of speaker at a podium
Member Highlights

Member Highlight: Meet Stefan Rose-John

Favorite cytokine? That’s easy: IL-6! A couple years ago, I organized an ICIS sponsored Interleukin-6 Meeting in Kiel together with Prof. Tadamitsu Kishimoto. This meeting brought together most of the scientists interested in this important cytokine. This is just one example of the opportunities to develop important friendships and collaborations [READ MORE]

Photo of the 2024 award winners in Seoul, Korea
Annual Meeting

Recognizing Excellence

ICIS Awards Celebrate Achievements Across Career Stages The International Cytokine & Interferon Society (ICIS) is proud to honor outstanding contributions to the field of cytokine and interferon research through its comprehensive awards program. Designed to recognize excellence at every stage of a scientist’s career, the ICIS awards underscore the Society’s [READ MORE]

Banner Image of ICIS President, Sarah Gaffen
Featured Article!

Presidents Message: Looking forward to 2025!

It’s hard to believe that its already 2025. Reflections We have compiled answers from the survey of attendees at the Seoul ICIS meeting, which confirmed our own feelings about the success of this conference. Kudos again to Drs. You-Me Kim and Sang-Il Lee, and our Korean Association of Immunologists (KAI) [READ MORE]

Conference attendees in an auditorium
Annual Meeting

2024 Travel Award Winners Recount Highlights of Cytokines 2024 & KAI 2024

Former travel grant recipient Dr. Maialen Sebastian de la Cruz of the University of the Basque Country (UPV/EHU) in Spain is an editor of the Signals+ newsletter. She interviewed the 2024 winners to capture their impressions while still fresh. The 12th Annual Meeting of the International Cytokines and Interferon Society [READ MORE]

Supporting trainees identifying & characterizing cytokines or antibodies to cytokines that directly impact patient lives
Featured Article!

Year-End Giving: Support the Next Generation of Scientific Discovery

As the year winds down and the spirit of generosity fills the air, many of us look for meaningful ways to give back. It’s a time of celebration, reflection and connection — an opportunity to align our actions with the causes that resonate most deeply with us. This year, consider [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials – updated December 18, 2024

1) Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study | 2) Impact of Smoking on Salivary Interleukin (IL)-39, IL-41, IL-1β, TNF-α Levels in Periodontal Disease | 3) Targeting IL-17A for Treatment-Resistant Depression [READ MORE]

Reviews of Interest

Reviews of Interest Curated by Dr. Zhian (Anthony) Chen

Photo Credit: Burcu Elmas (pexels.com 10051526) From periphery to center stage: 50 years of advancements in innate immunity. PMID: 38670064 Carpenter S, O’Neill LAJ. Cell. 2024 Apr 25;187(9):2030-2051. doi: 10.1016/j.cell.2024.03.036.PMID: 38670064 Free article. Review. Principles and therapeutic applications of adaptive immunity. PMID: 38670065 Chi H, Pepper M, Thomas PG. Cell. [READ MORE]

Banner image for FOCiS 2025
Other Meetings

FOCiS 2025 Annual Meeting is June 24 – 27 in Boston, Massachusetts

The Federation of Clinical Immunology Societies (FOCIS) is holding its 25th Annual Meeting, FOCIS 2025 in Boston, Massachusetts. The meeting will take place, in person, June 24-27, 2025, at the Boston Marriott Copley Place. Abstract submission is currently open. Registration and hotel accommodation will open soon. For regular updates, please [READ MORE]

Prof. You-Me Kim, Ph.D
Society News

Honoring Service and Welcoming New Opportunities: Thank You to Professor You-Me Kim

Turnover on governing councils is vital to the health and growth of not-for-profit organizations, bringing fresh ideas, new perspectives, and expanded networks. It’s a best practice embraced by over 85% of nonprofit boards. Yet, as effective as it is, turnover is often bittersweet. With this in mind, ICIS extends heartfelt [READ MORE]